Cortivazol

Star0

DB13003InvestigationalSmall molecule

Cortivazol is under investigation in clinical trial NCT00804895 (Cluster Headache Cortivazol Injection (CHCI)).

Mechanism: Pharmacologically active on Glucocorticoid receptor
Curator reviewed
Formula / weight: C₃₂H₃₈N₂O₅ · 530.665 g/mol (avg)
Code names: NSC-80998

Resolves to

Compound

UNIIYM183K0H63CAS1110-40-3ChEMBLCHEMBL2105842ChEBI135820PubChem66249

Clinical / RWD

RxNorm21660ATCH02AB17

Structure

InChIKeyRKHQGWMMUURILY-UHRZLXHJSA-NSMILESC[C@@H]1C[C@H]2[C@@H]3C=C(C)C4=CC5=C(C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O)C=NN5C1=CC=CC=C1

Targets

P04150NR3C1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1,205Drug interactionsStructured to mechanism, not free text

2Clinical trialsPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 18 drug categories

10+ReferencesStructured and connected to the statements they support

Which drugs share a target with Cortivazol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account